Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 2, 2023 5:30 P.M.
Form:
S-3
CIK:
0001990550
Company Name:
Ambrx Biopharma, Inc.
File Number:
333-275053